Technology Development Board (TDB), Department of Science & Technology (DST), Government of India has extended support to M/s Bioneemtec India Private Limited, Chennai
Project title: "Manufacturing of Minoxidil, Tranexamic Acid, Dequalinium Chloride, their Intermediates and Drug Liposomes"
Project seeks to commercialize indigenous green chemistry technologies for production of critical pharmaceutical ingredients and advanced drug delivery systems
Objectives include import substitution, sustainable manufacturing, and healthcare security
Focus on establishing advanced manufacturing capabilities for pharmaceutical intermediates, Active Pharmaceutical Ingredients (APIs), and novel drug delivery systems
Uses combination of batch and continuous-flow chemistry technologies
Aims to improve production efficiency, product quality, operational safety, and environmental sustainability
Reduces dependence on imported pharmaceutical intermediates
Key component: commercialization of indigenous process for manufacturing Tranexamic Acid (used in management of bleeding disorders)
Technology uses cost-effective and environmentally responsible synthesis route
Delivers high-purity products while minimizing waste generation and process complexity
Supports domestic production of Minoxidil and Dequalinium Chloride along with their key intermediates
Strengthens local manufacturing capabilities in pharmaceutical value chains
Bioneemtec has developed proprietary Drug Liposome APIs based on advanced nanotechnology platforms
Liposomal formulations being developed for therapeutic applications including breast and skin cancer management
Formulations have demonstrated promising results with controlled nanoparticle characteristics
Company has initiated intellectual property protection for the technology
Creates foundation for future development of advanced targeted drug delivery solutions
